Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
09/2010
09/16/2010US20100234332 Novel quinuclidine derivatives and medicinal compositions containing the same
09/16/2010US20100234305 Polymeric delivery formulations of leuprolide with improved efficacy
09/16/2010US20100234300 A purified pro-cytolytic peptide; used to treat localized and metastatic prostate cancer; administered intratumorally and/or intraprostatically
09/16/2010US20100233735 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
09/16/2010US20100233281 Process for decreasing environmental pollutants in an oil or a fat.
09/16/2010US20100233260 Pharmaceutical composition for oral administration
09/16/2010US20100233255 Combination of trazine derivatives and insulin secretion stimulators
09/16/2010US20100233191 Method of treating or preventing benign prostatic hyperplasia using modified pore-forming proteins
09/16/2010US20100233179 BAFF, inhibitors thereof and their use in the modulation of B-cell response
09/16/2010US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides
09/16/2010US20100233158 Induction of immune tolerance
09/16/2010US20100233143 Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells
09/16/2010US20100233091 Pyrazine Derivatives with Extended Conjugation and Methods of Using the same in Optical Applications
09/16/2010CA2755197A1 Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of raf kinases
09/16/2010CA2755045A1 Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of raf kinases
09/16/2010CA2751901A1 Mineralocorticoid receptor antagonist and methods of use
09/15/2010EP2228389A2 Antibodies against vascular endothelial growth factor 2
09/15/2010EP2228385A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
09/15/2010EP2228384A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
09/15/2010EP2228071A1 Intra-vascular kidney gene therapy with plasmid encoding BMP-7
09/15/2010EP1968561B1 Treatment of diabetic nephropathy
09/15/2010EP1354196B1 Diagnostics, drug screening and treatment for cancer
09/15/2010CN101835747A Benzimidazole derivative
09/15/2010CN101831378A Vinegar and brewing technology thereof
09/15/2010CN101830916A Cefbuperazone sodium hydrate, preparation method thereof and application thereof
09/15/2010CN101830889A 嘧啶衍生物 Pyrimidine derivatives
09/15/2010CN101830876A C-aryl glucoside derivative, preparation method thereof and application thereof in medicine
09/15/2010CN101829325A Pharmaceutical composition for treatment of diseases caused by IL-6 production
09/15/2010CN101829318A Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
09/15/2010CN101829303A Longevity wine
09/15/2010CN101829299A External use paste for preventing and treating prostatosis and preparation method thereof
09/15/2010CN101829295A Preparation for treating urinary tract stones and preparation method thereof
09/15/2010CN101829288A Medicament for treating prostatic hyperplasia
09/15/2010CN101829273A Detoxifying pills for kidney, intestine, bladder and urethra diseases and preparation method thereof
09/15/2010CN101829270A Traditional Chinese medicine preparation for treating chronic renal failure and preparation method
09/15/2010CN101829264A Medicine composition for treating hyperuricemia and related diseases and preparation method and application thereof
09/15/2010CN101829259A Footbath effervescent tablet for improving prostatitis
09/15/2010CN101829207A Kidney capsules with seven components and preparation method thereof
09/15/2010CN101829188A Medicament for treating urinary infection and lithiasis
09/15/2010CN101829182A Medicament for treating prostatic diseases
09/15/2010CN101829116A PTEN inhibitor or MAXI-K channels opener
09/15/2010CN101829081A Application of chromane compound HEF-05 in relaxing smooth muscle of blood vessel
09/15/2010CN101829077A Application of dicaffeoyl-quinic acid derivative in preparing drugs for treating mycoplasma infection diseases
09/15/2010CN101239123B Medicaments for treating renal failure
09/15/2010CN101229373B Medicine compounds for treating diabetic nephropathy
09/15/2010CN101125134B Hydrochloric tamsulosin sustained-release capsule and its preparation method
09/15/2010CN101069742B Pancreatic kininogenase tablet and preparing method
09/15/2010CN101019848B Application of ferricitras in preparation of medicine to prevent and treat angiosteosis
09/14/2010US7795494 Transgenic animals capable of generating antibodies, e.g., human monoclonal antibodies, specific for the product of a gene of interest
09/14/2010US7795428 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
09/14/2010US7795281 (R)-2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 3-(1-diphenylmethylazetidin-3-yl) ester 5-isopropyl ester; calcium antagonistic action, antihypertensive action, vascular dilatory action, cardiac protective action, anti-arteriosclerotic action, diuretic action
09/14/2010US7795214 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases
09/14/2010CA2479353C N-substituted benzothiophenesulfonamide derivative
09/14/2010CA2441501C Rho-kinase inhibitors
09/10/2010WO2010101230A1 Quinoxaline compounds
09/10/2010WO2010101164A1 Pyridine derivative
09/10/2010WO2010101128A1 Amide compound
09/10/2010WO2010101127A1 Indole compound
09/10/2010WO2010100248A1 Use of pyrimidylaminobenzamide derivatives for the treatment of disorders mediated by the leucine zipper- and sterile alpha motif-containing kinase (zak)
09/10/2010WO2010100112A1 Phosphate adsorbent
09/10/2010CA2754457A1 Quinoxaline compounds
09/10/2010CA2754446A1 Pyridine derivative
09/10/2010CA2753637A1 Use of pyrimidylaminobenzamide derivatives for the treatment of disorders mediated by the leucine zipper- and sterile alpha motif-containing kinase (zak)
09/10/2010CA2753364A1 Phosphate adsorbent
09/09/2010US20100228018 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/09/2010US20100227934 Therapeutic compounds and methods of use
09/09/2010US20100227923 Preventive/remedy for urinary calculosis
09/09/2010US20100227883 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
09/09/2010US20100227797 Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives
09/09/2010US20100226981 Oral dosage forms having a high loading of a gabapentin prodrug
09/09/2010US20100226980 Novel tablet based on s-adenosyl-methionine
09/09/2010US20100226954 Polymeric delivery formulations of leuprolide with improved efficacy
09/09/2010US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides
09/08/2010EP2226632A1 Method for screening of cell-protecting agent
09/08/2010EP2226324A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines for use in the treatment of diabetes type ii
09/08/2010EP2226085A1 Anti-angiogenic compositions and methods of use
09/08/2010EP1478624B1 Chemical compounds
09/08/2010EP1320531B1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
09/08/2010EP1085905B1 Immunotherapeutic composition and method for the treatment of prostate cancer
09/08/2010CN1970025B Chinese medicinal biological agent of 'Liu Wei Di Huang' decoction and preparation process thereof
09/08/2010CN1939453B Gambir plant extract and its use in preparation of target organ protective medicine
09/08/2010CN1923205B Application of (-)doxazosin in preparing medicine for treating lower urinary tract symptom and bladder excessive activities diseases
09/08/2010CN1798746B Reverse-turn mimetics and method relating thereto
09/08/2010CN1736381B Use of morpholine methyltetralone in preparation of smooth muscles spasmolytic
09/08/2010CN1659144B Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
09/08/2010CN101822837A Medicine composition containing allisartan isoproxil salts
09/08/2010CN101822836A Medicine composition containing allisartan isoproxil
09/08/2010CN101822804A Medicament for treating urinary system calculus and preparation method thereof
09/08/2010CN101822787A Externally applied Chinese patent medicine for treating uremia and preparation method thereof
09/08/2010CN101822757A Method for preparing wine for clearing away heart heat and softening liver
09/08/2010CN101822753A Medicine for treating prostatitis and preparation method thereof
09/08/2010CN101822745A Externally applied Chinese patent medicine for treating prostatosis and preparation method thereof
09/08/2010CN101822742A Medicament for treating chronic nephritis and preparation method thereof
09/08/2010CN101822711A Preparation method of traditional Chinese medicine perfusate and application
09/08/2010CN101632660B Suspensoid powder injection of amoxicillin sodium sulbactam sodium medicine composition and novel application thereof
09/08/2010CN101124993B Production method of health-care food for lithiasis patient
09/08/2010CN101095668B Application of rosmarinic acid in the preparation of medicines for treating or preventing liver fibrosis and kidney fibrosis
09/08/2010CN101036725B Chinese traditional medicine for treating nephrolithiasis
09/08/2010CN101036682B Method for preparing epimedium brevicornum wine
09/08/2010CN101014329B Pharmaceutical composition for preventing or treating rejection reaction of organ or tissue transplant, host resistance reaction of implant in bone marrow transplantation